PD-L1 is a T-cell inhibitory receptor, expressed on tumor cells and antigen presenting cells (APC); it leads to T-cell anergy and/or apoptosis upon ligation to its receptor programmed death-1 (PD-1) on T-cells in BC as well as in other malignancies [22,23,24,25]. This evidence concerns the gene CD274 and neoplasm.